Technocrats Plasma Systems IPO (14-18 August) Analysis

IPO Analysis | BSE SME | 100% Book Built Issue (Pure Fresh Issue) | Regulation 229(2) and 253

Based on Draft Red Herring Prospectus dated December 31, 2025 | Plasma Cutting Machines, Welding Equipment and Automation Systems | Vasai, Maharashtra

STATUS: DRHP FILED | PRE-SEBI OBSERVATION STAGE | ALL BID DATES AND PRICE BAND TO BE DETERMINED

Pure Fresh Issue of up to 46,20,000 Equity Shares | No Offer for Sale | BSE SME Platform

Revenue Grew More Than 8x in FY25, But Gross Margin Compressed Sharply in the Same Period | RoNW of 90.21% (FY25) Well Above All 4 Listed Peers

NOTABLE DISCLOSURE:

The Statutory Auditor's report on the Company's financial statements for Fiscal 2022-23 included a Qualified Opinion, citing unconfirmed and unreconciled trade receivables, trade payables, and loans and advances, and a lack of proper inventory records and reconciliation for raw materials and semi-finished goods that year, meaning the impact of these gaps on that year's financial statements could not be ascertained. The Company states it has since taken corrective measures. Separately, discrepancies have been identified in certain RoC filings (including a share allotment filed under an incorrect Companies Act section), for which the Company has voluntarily filed an adjudication application, currently pending. See Section 6 for full detail.

 Technocrats Plasma Systems Limited was incorporated as Technocrat Plasma Systems Private Limited on November 1, 1994, renamed Technocrats Plasma Systems Private Limited in 2021, and converted to a public limited company in October 2025. Its CIN is U74999MH1994PLC082603, with its registered and corporate office in Sativali, Vasai East, Palghar, Maharashtra. The Promoters are Arun Kumar and Vandana Sharma.

The Company manufactures and supplies plasma cutting machines, welding equipment and customised automation systems for metal fabrication and industrial applications, including CNC-controlled and manual cutting machines.

The Company has been involved in introducing plasma cutting machines and inverter-based technology manufactured in India, and in implementing CNC plasma cutting and welding automation solutions, since its incorporation.

It operates from 2 manufacturing units in Sativali, Vasai East, and its offerings span commissioning, operator training, maintenance and after-sales technical support alongside its core equipment sales.

Revenue from operations grew from Rs.445.59 Lakhs in Fiscal 2023 to Rs.4,935.68 Lakhs in Fiscal 2025, more than 8 times, and reached Rs.3,068.24 Lakhs in the 3 month stub period ended June 30, 2025 alone (already 62% of the entirety of FY25). PAT grew from Rs.150.99 Lakhs to Rs.810.96 Lakhs over the same 2 years, with a further Rs.355.43 Lakhs in the stub period.

However, this dramatic revenue growth was accompanied by a sharp deterioration in gross margin, with cost of goods sold rising from 37.87% of revenue in FY23 to 73.80% in FY25 and further to 80.30% in the stub period, a genuine and important nuance discussed in detail in Section 4.

Key Basics

Particulars	Details
Document Type	Draft Red Herring Prospectus (DRHP) dated December 31, 2025. Pre-SEBI observation stage; all [TBD] items including Price Band and Bid dates remain undetermined.
Issue Structure	100% Book Built Issue, entirely a Fresh Issue of up to 46,20,000 Equity Shares (no Offer for Sale). Face value Rs.10 per share.
Face Value	Rs.10 per Equity Share.
Promoters	Arun Kumar and Vandana Sharma.
Selling Shareholders	Not applicable. This Issue is entirely a Fresh Issue; there is no Offer for Sale.
Eligibility Route	Regulation 229(2) and 253 of Chapter IX of the SEBI ICDR Regulations, 2018.
Listing Exchange	SME Platform of BSE Limited (BSE SME); in-principle approval not yet obtained as of this DRHP.
BRLM	Rarever Financial Advisors Private Limited.
Registrar	Maashitla Securities Private Limited.
Bid or Issue Dates	Not yet determined; this is a DRHP at pre-SEBI observation stage.
Listed Peers, One Line	4 listed peers (Ador Welding, ESAB India, Patil Automation, Jyoti CNC Automation), all substantially larger, with RoNW below the Company's own disclosed figure.

This is a long-established (incorporated 1994) SME manufacturer in a specialised industrial equipment niche. The most important feature to weigh alongside the Company's dramatic recent revenue growth is a sharp and sustained decline in gross margin over the same period, and a Qualified Opinion in the Statutory Auditor's report for Fiscal 2023, both discussed in Sections 4 and 6.

How Will the IPO Money Be Used?

Object	Estimated Amount (Rs. Thousand)	Substantiation
Purchase and installation of plant and machinery for manufacturing plasma cutting machines, welding equipment and customised automation systems at Existing Premises (2 named units)	878.56	A specific rupee figure disclosed, scheduled for full deployment within FY 2026-27; the Company's own Risk Factors disclose that orders for this machinery have not yet been placed as of this DRHP.
Funding towards long-term working capital requirements	4,406.72	The largest single Object by a wide margin, a specific rupee figure disclosed; based on internal management estimates and not independently appraised by any bank or financial institution.
General corporate purposes	[TBD]	Capped at 15% of Gross Proceeds or Rs.10 Crore, whichever is lower. No further breakdown provided, as is standard.

Working capital is by far the dominant Object of this Issue, reflecting the Company's own disclosed need given its long production cycles and the specialised, inventory-intensive nature of its custom equipment manufacturing.

The capital expenditure Object is directed at the Company's 2 existing manufacturing units rather than a new greenfield site, which somewhat limits execution complexity, though the Company's own Risk Factors explicitly disclose that it has not yet taken steps to order the new machinery and equipment required, leaving cost and timing execution risk open.

As this is still a DRHP, the Gross Proceeds, Net Proceeds and General Corporate Purposes figures all remain undetermined.

Financial Performance

P&L and Key Metrics (Rs. Lakhs unless stated)

Particulars	Q1 FY26 (Jun 2025)	FY 2025	FY 2024
Revenue from operations	3,068.24 (Q1, not annualized)	4,935.68	606.23
Cost of goods sold (% of revenue)	80.30 (Q1)	73.80	39.78
EBITDA	497.75 (Q1)	859.25	129.84
EBITDA margin (%)	16.22 (Q1)	17.41	21.42
Profit after tax	355.43 (Q1, not annualized)	810.96	220.51
PAT margin (%)	11.58 (Q1)	16.44	36.38
Return on net worth / RoNW (%)	21.19 (not annualized)	90.21	83.76

Independently recomputed, revenue grew approximately 36.0% in FY24 before exploding 714.5% in FY25 (Rs.606.23 Lakhs to Rs.4,935.68 Lakhs), and had already reached Rs.3,068.24 Lakhs in the 3 month stub period through June 2025 alone. PAT grew from Rs.150.99 Lakhs (FY23) to Rs.220.51 Lakhs (FY24) to Rs.810.96 Lakhs (FY25), also a dramatic increase.

However, the composition of this growth deserves close attention: cost of goods sold as a percentage of revenue nearly doubled, from 39.78% in FY24 to 73.80% in FY25, and rose further to 80.30% in the Q1 FY26 stub period, while EBITDA margin correspondingly declined from 21.42% (FY24) to 17.41% (FY25) to 16.22% (Q1 FY26), and PAT margin fell even more sharply, from 36.38% (FY24) to 16.44% (FY25) to 11.58% (Q1 FY26).

This pattern, revenue and absolute profit both growing strongly while margins compress steadily, most plausibly reflects a shift in the Company's Fiscal 2025 revenue mix toward larger, higher-value but lower-margin contracts (such as bulk equipment supply or larger automation projects with greater pass-through material costs) rather than its historically smaller, higher-margin core plasma cutting machine sales.

The DRHP excerpt reviewed here does not provide a segment-level breakdown confirming this explanation, so investors should specifically request or review the Company's own Management Discussion and Analysis section for the precise driver before relying on the FY25 revenue run-rate as indicative of the Company's ongoing margin profile.

How Does It Compare to Peers?

Company	Revenue FY25 (Rs. Lakhs)	Basic/Diluted EPS (Rs.)	P/E (times)	RoNW (%)	NAV/Share (Rs.)
Technocrats Plasma Systems Limited	494.42	52.25	N/A (Price TBD)	90.21	869.80
Ador Welding Limited	11,41,480.00	34.51	30.40	11.84	291.38
ESAB India Limited	13,81,250.00	113.96	53.36	48.56	234.68
Patil Automation Ltd	1,22,044.50	7.62	23.36	21.80	33.51
Jyoti CNC Automation Ltd	18,32,180.00	13.90	71.10	18.74	74.14

The DRHP discloses 4 listed peers in the welding and industrial automation equipment space, all substantially larger than Technocrats Plasma Systems by revenue, ranging from roughly 25 times (Patil Automation) to 370 times (Jyoti CNC Automation) larger.

On RoNW, the Company's FY25 figure of 90.21% is dramatically higher than all 4 peers (ranging from 11.84% to 48.56%), though this reflects the Company's very small pre-Offer equity base rather than being directly comparable to these much larger, more capital-intensive peers.

The industry P/E range is wide (23.36 to 71.10 times), and the Company's own P/E cannot yet be calculated pending Issue Price determination. Given the scale gap, this comparison should be read as limited, directional context rather than a precise valuation benchmark.

Key Risks

l The Statutory Auditor's report on the Company's financial statements for Fiscal 2022-23 included a Qualified Opinion (not merely an emphasis of matter), citing that certain trade receivables, trade payables, advances to suppliers, and loans and advances given and taken were subject to unresolved confirmation and reconciliation with the respective parties, and that the Company had not maintained proper records and reconciliation of inventory (including raw materials and semi-finished goods) that year, meaning the impact on that year's financial statements could not be ascertained by the auditor. The Company states it has since strengthened its reconciliation processes, inventory management systems and internal controls.

l Revenue grew more than 8 times from FY23 to FY25, but gross margin compressed sharply over the same period, with cost of goods sold rising from 37.87% to 73.80% of revenue (and further to 80.30% in the Q1 FY26 stub period) and PAT margin falling from 36.38% to 16.44% to 11.58% over the same window; the underlying driver of this margin compression is not detailed in the excerpt reviewed here and should be specifically confirmed before assuming the FY25 revenue level reflects a stable, ongoing margin profile.

l Discrepancies have been identified in certain statutory filings with the Registrar of Companies, including a mismatch between a share allotment's underlying corporate resolutions (which characterised it as a Section 62(1)(c) preferential allotment) and the e-form actually filed (under Section 62(3), as a loan conversion), and a discrepancy in the CFO's recorded resignation date; the Company has voluntarily filed an adjudication application under Section 454 of the Companies Act for one preferential allotment matter, which remains pending as of this DRHP.

l The Company has not yet taken any steps to order the new machinery and equipment required for its Existing Premises, the subject of this Issue's largest capital expenditure line item, leaving cost and timing execution risk open.

l The Company's net cash flows have been negative in some past years, and it cannot assure investors this will not recur; the Company also has outstanding debts requiring significant cash flows to service, secured in part by personal guarantees of its Promoters.

l Revenue is significantly dependent on the top 10 customers and on certain geographical regions, and manufacturing operations are concentrated in Maharashtra, without long-term customer contracts in most cases.

l The Company's Restated Financial Statements have been provided by a Peer Reviewed Chartered Accountant who is not the Company's Statutory Auditor, a structure the Company itself flags as a standalone risk factor.

l There have been instances of delayed statutory filings with the Registrar of Companies spanning 2007 through 2014 (Form 5, Form 66, Form 23B, GNL 2), and certain instances of delayed payment of statutory dues.

l The Company depends on a limited number of suppliers for material requirements without long-term supply agreements, and is exposed to global shortages and pricing volatility in electronic components and semiconductors used in its products.

l The Company faces intense competition from international players with larger R&D budgets, and is exposed to technological obsolescence risk in a rapidly evolving manufacturing and fabrication landscape.

l The Company relies on third-party service providers for warehousing operations in Mumbai and third-party transportation providers for product delivery, and trade receivables form a major part of current assets and net worth.

l There are certain outstanding legal proceedings involving the Company, its Directors and Promoters, and the Company's insurance coverage may not be adequate to protect against all potential losses.

Positives to Note

l The Company has a genuinely long operating history, tracing back to 1994, more than 3 decades of manufacturing experience in plasma cutting and welding equipment ahead of this listing.

l Both revenue and absolute PAT have grown very substantially across the disclosed track record (revenue more than 8 times, PAT more than 5 times, from FY23 to FY25), indicating strong underlying demand growth for the Company's products even as margins have compressed.

l RoNW of 90.21% in FY25 is dramatically higher than all 4 disclosed listed peers (ranging from 11.84% to 48.56%), reflecting efficient use of the Company's currently small equity base.

l The Company has proactively disclosed and begun remediating the specific gaps identified in its Fiscal 2023 audit qualification, including implementing enhanced inventory management systems and strengthening reconciliation processes and internal controls.

l The Company voluntarily identified and self-reported its RoC filing discrepancies through a physical search at the Registrar's office, and has proactively filed for adjudication on the preferential allotment matter rather than leaving it unaddressed.

l The working capital Object of this Issue is directly aligned with the Company's own disclosed need given its long production cycles and specialised, custom-built product portfolio, rather than an unrelated or opportunistic use of proceeds.

Disclaimer

The content on this website is for informational and educational purposes only and should not be construed as investment advice, a recommendation, or a solicitation to buy or sell any security, mutual fund, or financial instrument. Equity Research India is not a SEBI-registered investment advisor or research analyst, and nothing on this site constitutes personalized financial advice.

Mutual fund investments are subject to market risks. Please read all scheme-related documents carefully before investing. Past performance is not indicative of future returns. NAV, returns, rankings, and other data may change and may not reflect the most current information at the time of reading.

Readers should conduct their own due diligence and consult a SEBI-registered financial advisor before making any investment decisions. Equity Research India and its authors accept no liability for any loss or damage arising from the use of this content.